Univercell Biosolutions Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Out of Business

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Out of Business

Univercell Biosolutions General Information

Description

Developer of human stem cells, cellular reprogramming and differentiation technologies designed to accelerate drug discovery and development with more informative and innovative human cell models. The company's technologies offer collaborations with relevant and robust human-induced pluripotent stem cells tailored to fit with most differentiation protocols, enabling customers and medical care professionals to get access to well-characterized and standardized human-induced pluripotent stem cells (hiPSc).

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • 1 Place Pierre Potier
  • Canceropole, Entree B
  • 31106 Toulouse Cedex
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Univercell Biosolutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 14-Jul-2021 Completed Out of Business
3. Later Stage VC Completed Generating Revenue
2. Grant 31-Jan-2017 $53.2K Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Univercell Biosolutions’s complete valuation and funding history, request access »

Univercell Biosolutions Patents

Univercell Biosolutions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2594635-A1 Method for generating primate cardiovascular progenitor cells for clinical and drug cells testing use from primate embryonic stem cells or embryonic-like state cells, and their applications Inactive 18-Nov-2011 0000000000 0
US-20140302155-A1 Production of a human beta cell line from an early post natal pancreas Active 18-Oct-2011 0000000000 0
ES-2634457-T3 Production of a human beta cell line from an early postnatal pancreas Active 18-Oct-2011 00000000000
US-9493743-B2 Production of a human beta cell line from an early post natal pancreas Active 18-Oct-2011 0000000000 0
EP-2768948-A1 Production of a human beta cell line from an early post natal pancreas Active 18-Oct-2011 C12N5/0676
To view Univercell Biosolutions’s complete patent history, request access »

Univercell Biosolutions Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Univercell Biosolutions Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
EndoCells 01-Dec-2015 0000000000 Biotechnology
To view Univercell Biosolutions’s complete acquisitions history, request access »

Univercell Biosolutions FAQs

  • When was Univercell Biosolutions founded?

    Univercell Biosolutions was founded in 2010.

  • Who is the founder of Univercell Biosolutions?

    Guillaume Costecalde is the founder of Univercell Biosolutions.

  • Where is Univercell Biosolutions headquartered?

    Univercell Biosolutions is headquartered in Toulouse Cedex, France.

  • What is the size of Univercell Biosolutions?

    Univercell Biosolutions has 11 total employees.

  • What industry is Univercell Biosolutions in?

    Univercell Biosolutions’s primary industry is Biotechnology.

  • Is Univercell Biosolutions a private or public company?

    Univercell Biosolutions is a Private company.

  • What is Univercell Biosolutions’s current revenue?

    The current revenue for Univercell Biosolutions is 000000.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »